Clinical Trial Update: A Dose Escalation Study of APR003 in Patients With Advanced Colorectal Cancer (CRC) With Malignant Liver Lesions [Phase 1]

View source ↗

Summary

A dose-escalation Phase 1 trial of APR003 in patients with advanced colorectal cancer and malignant liver lesions has been terminated, with results posted on 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• APR003

Snippet

Sponsor: Apros Therapeutics, Inc | Conditions: Advanced Colorectal Carcinoma | Phase 1 | Status: TERMINATED | Results posted: 2025-08-06